Robert Hershberg Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

Robert Hershberg is Director of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 51,716 shares of RXRX, which is worth approximately $374,423. The most recent transaction as insider was on Jun 03, 2024, when has been sold 13,097 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.7K

0% 3M change

33.91% 12M change

Total Value Held $374,423

ROBERT HERSHBERG Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 03 2024	BUY Grant, award, or other acquisition	-	13,097 Added 20.21%	51,716 Class A Common Stock
Jun 16 2023	BUY Grant, award, or other acquisition	-	12,612 Added 24.62%	38,619 Class A Common Stock
Jun 14 2022	BUY Grant, award, or other acquisition	-	18,145 Added 41.1%	26,007 Class A Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	693 Added 8.1%	7,862 Class A Common Stock
Oct 01 2021	BUY Grant, award, or other acquisition	-	572 Added 7.39%	7,169 Class A Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	-	347 Added 5.0%	6,597 Class A Common Stock
Apr 20 2021	SELL Conversion of derivative security	-	6,250 Reduced 100.0%	0 Common Stock
Apr 20 2021	BUY Conversion of derivative security	-	6,250 Added 50.0%	6,250 Class A Common Stock
Apr 16 2021	BUY Grant, award, or other acquisition	-	6,250 Added 50.0%	6,250 Common Stock

Also insider at

ADPT

Adaptive Biotechnologies Corp Healthcare

Director

NSTG

NanoString Technologies Inc Healthcare

Director

SBTX

Silverback Therapeutics, Inc. Healthcare

Director

FATE

FATE THERAPEUTICS INC Healthcare

Director

HLVX

HilleVax, Inc. Healthcare